PR.com: Business Directory, Press Releases, Jobs, Products, Services, Articles
 
Businesses Articles Press Releases Follow @PRcom
Press Release Pricing | News by Category | News by Country | News by US Region | Recent News | PR.com News on Your Site
 

Press Releases

 

AbboMax, Inc

Press Release


Receive press releases from AbboMax, Inc: By Email RSS Feeds:
Recent Progress in Neuroscience Research and the New Anti-GABAB1 Receptor Antibody from AbboMax, Inc.

Neurotransmitters are chemical messengers that transmit and modulate signals from neurons to other cells of the brain and body. GABA is the most prevalent inhibitory neurotransmitter in the mammalian central nervous system. GABA receptors are promising drug targets for a wide spectrum of psychiatric and neurological disorders. AbboMax, Inc. offers new anti-GABAB1 receptor polyclonal antibody as well as an extensive collection of neuroscience related antibodies.

San Jose, CA, December 19, 2013 --(PR.com)-- Neurotransmitters are chemical messengers that transmit and modulate signals from neurons to other cells of the brain and body across a synapse. When a neurotransmitter binds to its corresponding receptor, it activates or inhibits the receptor's associated pathway.

GABA, the most prevalent inhibitory neurotransmitter in the mammalian central nervous system, plays an essential role in regulating vital neurological functions. GABA’s natural function is to reduce the activity of the neurons to which it binds through GABA receptors (GABARs).

Regulation of both excitatory and inhibitory synaptic transmission is critical for proper nervous system function. GABARs are promising drug targets for a wide spectrum of psychiatric and neurological disorders. They are involved in sedative and anxiolytic activities. Enhancement of GABA signaling has been demonstrated in patients with central nervous system hypersomnias. GABA-ergic disturbances are hallmark features of schizophrenia and other neuropsychiatric disorders. GABA-ergic system has been associated consistently with atypicalities in autism and aggressive behavior. Modulators of the GABARs may be useful in the treatment of visual, sleep, and cognitive disorders. GABARs have been associated with seizures and memory dysfunction when disrupted. The up-regulations of GABA in the brain may lead to an antiepileptic effect. The cerebellar cortex, the brain region responsible for motor coordination and learning expresses a high density of GABARs.

Repeated alcohol exposure during the third trimester of pregnancy increases expression of GABARs in cerebellar granule neurons and delays motor development in rats. Ethanol significantly reduces the brain metabolism, probably via action at specific GABARs. These receptors an important role in the neuroprotective effects of anthocyanins against ethanol. Interestingly, increased expression of GABARs has been detected in several human cancer cells and tissues.

It was demonstrated that the absence of functional GABARs disturbs glucose homeostasis in mice.

AbboMax offers new anti-GABAB1 receptor polyclonal antibody as well as an extensive collection of neuroscience related antibodies.

AbboMax, Inc. is a biotechnology company headquartered in San Jose, California, USA. The company offers innovative primary and secondary antibodies, peptides, antibody reagents, assay kits, and liposome reagents, as well as custom services.

Please contact us at: 408-321-9898
Natasha Raysberg, Ph.D.
Contact Information
AbboMax, Inc
Natasha Raysberg, Ph.D.
408-321-9898
Contact
www.abbomax.com

Click here to view the list of recent Press Releases from AbboMax, Inc
Promote Your Business